Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
The impact of ABCB1, CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation.
Journal: Drug metabolism and personalized therapy
Published: March 03, 2024
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: October 17, 2019
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Journal: Drug metabolism and personalized therapy
Published: October 13, 2019
Impact of atrial fibrillation on the rate of mild cognitive impairment in the elderly.
Journal: Journal of the neurological sciences
Published: June 05, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026